US296006A
(en)
|
|
1884-04-01 |
|
John hoefleb |
US3725540A
(en)
|
1970-07-30 |
1973-04-03 |
Procter & Gamble |
Color and odor stabilized dry aerosol antiperspirant
|
US4172149A
(en)
|
1978-01-30 |
1979-10-23 |
Westwood Pharmaceuticals, Inc. |
Method for treating living skin exhibiting excessive sebum secretion
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
US4908154A
(en)
*
|
1981-04-17 |
1990-03-13 |
Biotechnology Development Corporation |
Method of forming a microemulsion
|
US4533254A
(en)
*
|
1981-04-17 |
1985-08-06 |
Biotechnology Development Corporation |
Apparatus for forming emulsions
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
CA1283827C
(en)
|
1986-12-18 |
1991-05-07 |
Giorgio Cirelli |
Appliance for injection of liquid formulations
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
JPH0798740B2
(ja)
|
1987-10-28 |
1995-10-25 |
日本新薬株式会社 |
薬物担体
|
IL88076A
(en)
|
1987-10-28 |
1993-01-14 |
Nippon Shinyaku Co Ltd |
Fat emulsions as drug carriers
|
US5651991A
(en)
*
|
1987-10-28 |
1997-07-29 |
Nippon Shinyaku Co. Ltd. |
Drug carriers
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
US5008110A
(en)
*
|
1988-11-10 |
1991-04-16 |
The Procter & Gamble Company |
Storage-stable transdermal patch
|
CH677886A5
(es)
|
1989-06-26 |
1991-07-15 |
Hans Georg Prof Dr Weder |
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US5401243A
(en)
*
|
1990-08-21 |
1995-03-28 |
Associated Synapse Biologics |
Controlled administration of chemodenervating pharmaceuticals
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
JP3765579B2
(ja)
|
1990-08-24 |
2006-04-12 |
イーデーエーアー アーゲー |
作用物質投与用超微小滴状調剤
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
US5652274A
(en)
*
|
1991-03-01 |
1997-07-29 |
Martin; Alain |
Therapeutic-wound healing compositions and methods for preparing and using same
|
DE69127207T2
(de)
*
|
1991-05-03 |
1998-01-22 |
Raision Tehtaat Oy Ab |
Substanz zur absenkung eines hohen cholesterolspiegels im serum und verfahren zu ihrer herstellung
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
US6939852B2
(en)
|
1991-09-24 |
2005-09-06 |
Allergan, Inc. |
Methods and compositions for the treatment of cerebral palsy
|
US7384918B2
(en)
|
1991-09-24 |
2008-06-10 |
Allergan, Inc. |
Botulinum toxin for treating muscle contracture
|
GB9120306D0
(en)
*
|
1991-09-24 |
1991-11-06 |
Graham Herbert K |
Method and compositions for the treatment of cerebral palsy
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
IL101387A
(en)
|
1992-03-26 |
1999-11-30 |
Pharmos Ltd |
Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
|
US6010715A
(en)
*
|
1992-04-01 |
2000-01-04 |
Bertek, Inc. |
Transdermal patch incorporating a polymer film incorporated with an active agent
|
EP0571677A1
(en)
|
1992-05-29 |
1993-12-01 |
Unilever Plc |
Aqueous parfume oil microemulsions
|
EP0572080B1
(en)
|
1992-05-29 |
1995-11-15 |
Quest International B.V. |
Aqueous perfume oil microemulsions
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
US5591767A
(en)
*
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
US5576016A
(en)
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
US5470577A
(en)
|
1993-07-07 |
1995-11-28 |
Trustees Of Boston University |
Stimulation of tanning by DNA fragments or single-stranded DNA
|
IT1261849B
(it)
|
1993-09-02 |
1996-06-03 |
Avantgarde Spa |
Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
|
US8187612B2
(en)
*
|
1993-12-28 |
2012-05-29 |
Allergan, Inc. |
Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle
|
US6974578B1
(en)
|
1993-12-28 |
2005-12-13 |
Allergan, Inc. |
Method for treating secretions and glands using botulinum toxin
|
HUT74735A
(en)
|
1994-02-25 |
1997-02-28 |
Takeda Chemical Industries Ltd |
Injectable emulsion composition containing antifungal triazole derivatives and process for producing it
|
JPH07285863A
(ja)
|
1994-02-25 |
1995-10-31 |
Takeda Chem Ind Ltd |
注射剤組成物およびその製造方法
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
US5766605A
(en)
*
|
1994-04-15 |
1998-06-16 |
Mount Sinai School Of Medicine Of The City University Of New York |
Treatment of autonomic nerve dysfunction with botulinum toxin
|
US5670484A
(en)
|
1994-05-09 |
1997-09-23 |
Binder; William J. |
Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
|
ES2078190B1
(es)
|
1994-05-20 |
1996-08-01 |
Cusi Lab |
Procedimiento para el recubrimiento de goticulas o particulas de tamaño nanometrico.
|
US5843334A
(en)
|
1994-06-20 |
1998-12-01 |
Nippon Shinyaku Co., Ltd. |
Method of producing emulsions and an emulsification apparatus
|
US5672358A
(en)
|
1994-06-21 |
1997-09-30 |
Ascent Pharmaceuticals, Inc. |
Controlled release aqueous emulsion
|
ES2094688B1
(es)
|
1994-08-08 |
1997-08-01 |
Cusi Lab |
Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
|
DE4440337A1
(de)
*
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
US20020048596A1
(en)
*
|
1994-12-30 |
2002-04-25 |
Gregor Cevc |
Preparation for the transport of an active substance across barriers
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
US5629021A
(en)
*
|
1995-01-31 |
1997-05-13 |
Novavax, Inc. |
Micellar nanoparticles
|
US5510118A
(en)
*
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
FR2730932B1
(fr)
*
|
1995-02-27 |
1997-04-04 |
Oreal |
Nanoemulsion transparente a base de lipides amphiphiles non-ioniques fluides et utilisation en cosmetique ou en dermopharmacie
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
DK0773788T3
(da)
|
1995-06-06 |
2003-09-01 |
Allergan Inc |
Forbedrede præparater og fremgangsmåder til kemodenervering under anvendelse af neurotoxiner
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
US5660858A
(en)
*
|
1996-04-03 |
1997-08-26 |
Research Triangle Pharmaceuticals |
Cyclosporin emulsions
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
FR2755854B1
(fr)
*
|
1996-11-15 |
1998-12-24 |
Oreal |
Nanoemulsion a base de lipides amphiphiles non-ioniques et cationiques et utilisations
|
CN1265691C
(zh)
|
1996-12-19 |
2006-07-19 |
揖斐电株式会社 |
多层印刷布线板及其制造方法
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
FR2760970B1
(fr)
*
|
1997-03-18 |
2000-03-10 |
Oreal |
Nanoemulsions a base de lipides amphiphiles non-ioniques et de silicones aminees et utilisations
|
US5994414A
(en)
|
1997-04-28 |
1999-11-30 |
Avon Products, Inc. |
Water-thin emulsion formed by high pressure homogenization process
|
GB9708066D0
(en)
*
|
1997-04-22 |
1997-06-11 |
Woolcombers Group Plc |
Compositions and their use
|
JP4656675B2
(ja)
|
1997-05-14 |
2011-03-23 |
ユニバーシティー オブ ブリティッシュ コロンビア |
脂質小胞への荷電した治療剤の高率封入
|
US6835395B1
(en)
|
1997-05-14 |
2004-12-28 |
The University Of British Columbia |
Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
ES2385130T3
(es)
*
|
1997-07-15 |
2012-07-18 |
The Regents Of The University Of Colorado, A Body Corporate |
Uso de terapia con neurotoxinas para el tratamiento de enfermedades urológicas y de enfermedades relacionadas
|
US6007856A
(en)
|
1997-08-08 |
1999-12-28 |
The Procter & Gamble Company |
Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid
|
US5948433A
(en)
|
1997-08-21 |
1999-09-07 |
Bertek, Inc. |
Transdermal patch
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
RU2212230C2
(ru)
|
1998-03-05 |
2003-09-20 |
Ниппон Синяку Ко., Лтд. |
Жировая эмульсия для ингаляции
|
US5965154A
(en)
|
1998-03-17 |
1999-10-12 |
Plc Holding, L.L.C. |
Adhesive matrix type transdermal patch and method of manufacturing same
|
EP0953632B1
(de)
*
|
1998-03-30 |
2007-09-05 |
Mibelle AG Cosmetics |
Verwendung von Nanoemulsionen zur Bestimmung der Biokompatibilität von lipophilen Stoffen im Zellkultur-Test und dafür geeignete Nanoemulsionen
|
FI111513B
(fi)
*
|
1998-05-06 |
2003-08-15 |
Raisio Benecol Oy |
Uudet fytosteroli- ja fytostanolirasvahappoesterikoostumukset, niitä sisältävät tuotteet sekä menetelmät niiden valmistamiseksi
|
US5932562A
(en)
*
|
1998-05-26 |
1999-08-03 |
Washington University |
Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
|
GB9817052D0
(en)
*
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
GB9818548D0
(en)
|
1998-08-25 |
1998-10-21 |
Microbiological Res Authority |
Treatment of mucas hypersecretion
|
FR2783169B1
(fr)
|
1998-09-15 |
2001-11-02 |
Sederma Sa |
Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
|
US6242001B1
(en)
*
|
1998-11-30 |
2001-06-05 |
Mcneil-Ppc, Inc. |
Method for producing dispersible sterol and stanol compounds
|
DE19856897A1
(de)
*
|
1998-12-10 |
2000-06-15 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Therapeutikum zur Unterdrückung von Schnarchgeräuschen
|
DE69825495T2
(de)
|
1998-12-23 |
2005-07-28 |
Idea Ag |
Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
|
FR2787728B1
(fr)
*
|
1998-12-23 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras d'acide phosphorique, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
FR2788007B1
(fr)
*
|
1999-01-05 |
2001-02-09 |
Oreal |
Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
US20030229141A1
(en)
*
|
1999-01-08 |
2003-12-11 |
Yu Ruey J. |
N-acetyl cysteine and its topical use
|
US6635676B2
(en)
|
1999-04-28 |
2003-10-21 |
Regents Of The University Of Michigan |
Non-toxic antimicrobial compositions and methods of use
|
US20040009936A1
(en)
*
|
1999-05-03 |
2004-01-15 |
Tang De-Chu C. |
Vaccine and drug delivery by topical application of vectors and vector extracts
|
EP1189597A4
(en)
|
1999-06-04 |
2008-06-18 |
Pacira Pharmaceuticals Inc |
COMPOSITIONS USING AN OIL CORE FOR DELAYED RELEASE HYDROPHOLE MEDICAMENTS
|
WO2001001962A1
(en)
*
|
1999-07-05 |
2001-01-11 |
Idea Ag. |
A method for the improvement of transport across adaptable semi-permeable barriers
|
CA2377422A1
(en)
|
1999-08-04 |
2001-02-15 |
Idea Ag |
Periodic structures comprising lipids, polyelectrolytes, and structure- inducing soluble oligovalent linkers, and biological use thereof
|
US6358917B1
(en)
*
|
1999-08-24 |
2002-03-19 |
Jean D. A. Carruthers |
Cosmetic use of botulinum toxin for treatment of downturned mouth
|
US6720001B2
(en)
*
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
US7838008B2
(en)
|
1999-12-07 |
2010-11-23 |
Allergan, Inc. |
Methods for treating diverse cancers
|
US6429189B1
(en)
|
1999-12-10 |
2002-08-06 |
Botulinum Toxin Research Associates, Inc. |
Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases
|
NZ520312A
(en)
*
|
1999-12-28 |
2003-08-29 |
Bioniche Life Sciences Inc |
Hyaluronic acid in the treatment of cancer
|
US6898427B1
(en)
*
|
1999-12-29 |
2005-05-24 |
Bellsouth Intellectual Property Corporation |
Method of coupling portable communications device to first network by way of second network
|
US6967023B1
(en)
*
|
2000-01-10 |
2005-11-22 |
Foamix, Ltd. |
Pharmaceutical and cosmetic carrier or composition for topical application
|
FR2804015B1
(fr)
|
2000-01-21 |
2005-12-23 |
Oreal |
Nanoemulsion contenant des lipides amphiphiles et un polymere non ionique et utilisations
|
AU2001245947A1
(en)
|
2000-03-23 |
2001-10-03 |
Collaborative Technologies, Inc |
Method for preparing high pressure/high shear dispersions containing physiologically active ingredients
|
US6464986B1
(en)
*
|
2000-04-14 |
2002-10-15 |
Allegan Sales, Inc. |
Method for treating pain by peripheral administration of a neurotoxin
|
US6471968B1
(en)
|
2000-05-12 |
2002-10-29 |
Regents Of The University Of Michigan |
Multifunctional nanodevice platform
|
FR2809112B1
(fr)
|
2000-05-16 |
2004-05-07 |
Centre Nat Rech Scient |
Materiaux a base de polymeres biodegradables et son procede de preparation
|
FR2809010B1
(fr)
|
2000-05-22 |
2002-07-12 |
Oreal |
Nanoemulsion a base de polymeres anioniques, et ses utilisations notamment dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
US6670322B2
(en)
|
2000-06-01 |
2003-12-30 |
Wisconsin Alumni Research Foundation |
Method of targeting pharmaceuticals to motor neurons
|
US6306423B1
(en)
*
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
US20040033241A1
(en)
*
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
US20020155084A1
(en)
|
2000-06-02 |
2002-10-24 |
The Regents Of The University Of The Michigan |
Nanoemulsion formulations
|
FR2811561B1
(fr)
|
2000-07-13 |
2003-03-21 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase
|
US20040220100A1
(en)
|
2000-07-21 |
2004-11-04 |
Essentia Biosystems, Inc. |
Multi-component biological transport systems
|
US6455058B1
(en)
|
2000-09-13 |
2002-09-24 |
Amitee Cosmetics, Inc. |
Composition and method for hair and scalp treatment
|
FR2816949B1
(fr)
*
|
2000-11-17 |
2003-11-28 |
Centre Nat Rech Scient |
Copolymere a structure sequencee compose d'un segment saccharidique lie a au moins un segment hydrophobe bioerodable, et particules correspondantes
|
US7255865B2
(en)
*
|
2000-12-05 |
2007-08-14 |
Allergan, Inc. |
Methods of administering botulinum toxin
|
PT1345597E
(pt)
|
2000-12-27 |
2007-10-29 |
Ares Trading Sa |
Nanopartículas lipídicas anfifílicas para incorporação de péptidos e/ou proteínas
|
FI20010115A0
(fi)
|
2001-01-18 |
2001-01-18 |
Orion Corp |
Menetelmä nanopartikkelien valmistamiseksi
|
FR2819427B1
(fr)
*
|
2001-01-18 |
2003-04-11 |
Oreal |
Nanoemulsion translucide, son procede de fabrication et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
US20040048836A1
(en)
*
|
2001-03-23 |
2004-03-11 |
Wilmott James M |
Method for preparing high pressure/ high shear dispersions containing physiologically active ingredients
|
CA2442660A1
(en)
|
2001-03-30 |
2002-10-17 |
Color Access, Inc. |
Novel nanoemulsions
|
KR100463167B1
(ko)
|
2001-04-13 |
2004-12-23 |
주식회사 태평양 |
고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
|
AU2002367976B2
(en)
|
2001-06-05 |
2007-06-21 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
EP1269994A3
(en)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising drug and concentration-enhancing polymers
|
KR100566911B1
(ko)
*
|
2001-06-25 |
2006-04-03 |
주식회사 삼양사 |
약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
|
AU2002355730B2
(en)
*
|
2001-07-27 |
2007-09-13 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Botulinum toxin in the treatment or prevention of acne
|
WO2003015698A2
(en)
*
|
2001-08-13 |
2003-02-27 |
University Of Pittsburgh |
Application of lipid vehicles and use for drug delivery
|
DE10146647A1
(de)
|
2001-09-21 |
2003-04-24 |
Marc Heckmann |
Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis
|
US20030077240A1
(en)
*
|
2001-10-24 |
2003-04-24 |
Clariant International, Ltd. |
Use of high-purity phenylsilsesquioxane liquids for the preparation of cosmetic and pharmaceutical compositions
|
US7235230B2
(en)
*
|
2001-10-24 |
2007-06-26 |
Clariant Finance (Bvi) Limited |
Leave-on compositions for personal care
|
CA2465123A1
(en)
|
2001-10-30 |
2003-05-08 |
Pentapharm Ag |
Dermopharmaceutically and cosmetically active oligopeptides
|
US20030113349A1
(en)
*
|
2001-12-18 |
2003-06-19 |
Coleman William P. |
Topically applied clostridium botulinum toxin compositions and treatment methods
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
US6765001B2
(en)
|
2001-12-21 |
2004-07-20 |
Medicis Pharmaceutical Corporation |
Compositions and methods for enhancing corticosteroid delivery
|
KR100441167B1
(ko)
*
|
2001-12-27 |
2004-07-21 |
씨제이 주식회사 |
마이크로에멀젼 예비 농축액 조성물
|
EP1334729A1
(en)
|
2002-02-07 |
2003-08-13 |
Botulinum Toxin Research Associates, Inc. |
Therapeutic use of non-neurotoxic clostridium botulinum toxin type C2
|
US6861066B2
(en)
*
|
2002-03-11 |
2005-03-01 |
Health Plus International Inc. |
Method for the delivery of a biologically active agent
|
US6688311B2
(en)
*
|
2002-03-14 |
2004-02-10 |
Allergan, Inc. |
Method for determining effect of a clostridial toxin upon a muscle
|
US6623780B1
(en)
|
2002-03-26 |
2003-09-23 |
Cargill, Inc. |
Aqueous dispersible sterol product
|
US20040115159A1
(en)
*
|
2002-03-29 |
2004-06-17 |
Tadlock Charles C |
Novel nanoemulsions
|
US20060083778A1
(en)
*
|
2002-05-03 |
2006-04-20 |
Dean Allison |
Controlled release compositions of estradiol metabolites
|
US7491403B2
(en)
*
|
2002-12-20 |
2009-02-17 |
Botulinum Toxin Research Associates |
Pharmaceutical botulinum toxin compositions
|
US7459164B2
(en)
*
|
2002-05-28 |
2008-12-02 |
Botulinum Toxin Research Associates, Inc. |
Composition for therapeutic and cosmetic botulinum toxin
|
US7691394B2
(en)
|
2002-05-28 |
2010-04-06 |
Botulinum Toxin Research Associates, Inc. |
High-potency botulinum toxin formulations
|
AU2003231878A1
(en)
|
2002-05-31 |
2003-12-19 |
Solux Corporation |
Pharmaceutical preparation of botulinum neurotoxin, methods of synthesis and methods of clinical use
|
CA2488617A1
(en)
*
|
2002-06-10 |
2003-12-18 |
Eugene R. Cooper |
Nanoparticulate sterol formulations and sterol combinations
|
EP1531800B1
(en)
|
2002-06-11 |
2011-06-08 |
Ethypharm |
Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
|
US6996748B2
(en)
*
|
2002-06-29 |
2006-02-07 |
Intel Corporation |
Handling faults associated with operation of guest software in the virtual-machine architecture
|
US20040009180A1
(en)
*
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
ATE389675T1
(de)
*
|
2002-09-12 |
2008-04-15 |
3M Innovative Properties Co |
Fluorelastomere mit niedertemperatureigenschaften und lösungsmittelbeständigkeit
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
US20070292359A1
(en)
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
US7476393B2
(en)
|
2002-11-29 |
2009-01-13 |
L'oreal |
Process for the preparation of a cationic nanoemulsion, and cosmetic composition
|
US20040115727A1
(en)
*
|
2002-12-11 |
2004-06-17 |
Allergan, Inc., A Corporation |
Evolved clostridial toxins with altered protease specificity
|
DE10258960A1
(de)
|
2002-12-16 |
2004-07-01 |
Henkel Kgaa |
Nanoskalige Hydrogele gegen Falten, raue und trockene Haut
|
FR2849375B1
(fr)
|
2002-12-30 |
2006-10-20 |
Jean Noel Thorel |
Compositions cosmetiques, par exemple pour traiter le vieillissement cutane photo-induit
|
EP1587499A1
(en)
|
2003-01-31 |
2005-10-26 |
Elan Pharma International Limited |
Nanoparticulate topiramate formulations
|
JP2006516649A
(ja)
*
|
2003-02-05 |
2006-07-06 |
アンフォラ・ディスカヴァリー・コーポレイション |
局所適用による化粧剤の送達方法
|
WO2004076634A2
(en)
*
|
2003-02-24 |
2004-09-10 |
Ira Sanders |
Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
WO2004084839A2
(en)
*
|
2003-03-24 |
2004-10-07 |
Cady Roger K |
Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin
|
US20040191330A1
(en)
|
2003-03-31 |
2004-09-30 |
Keefe Candace R. |
Daily skin care regimen
|
EP1608403A2
(en)
|
2003-04-02 |
2005-12-28 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations for topical application
|
GB0312309D0
(en)
|
2003-05-29 |
2003-07-02 |
Gaslini Children S Hospital G |
Targeted liposome
|
US20050079228A1
(en)
*
|
2003-05-30 |
2005-04-14 |
Ashish Jaiswal |
Clear, stable topical compositions of clarithromycin and processes for their preparation
|
US20050208083A1
(en)
|
2003-06-04 |
2005-09-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
CA2528095C
(en)
|
2003-06-04 |
2014-10-14 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
|
EP1640017A1
(en)
*
|
2003-06-20 |
2006-03-29 |
Santen Pharmaceutical Co., Ltd. |
Remedies for diseases with hypermyotonia
|
JP5015594B2
(ja)
*
|
2003-06-23 |
2012-08-29 |
トランスファーマ メディカル リミテッド |
化粧剤用経皮送達システム
|
US7226487B2
(en)
*
|
2003-07-07 |
2007-06-05 |
The Procter & Gamble Company |
2-(amino or substituted amino)-5-(substituted oxymethyl)-phenol compounds, dyeing compositions containing them, and use thereof
|
JPWO2005013938A1
(ja)
|
2003-08-06 |
2006-09-28 |
エーザイ株式会社 |
薬物超微粒子の製造法及び製造装置
|
AU2004263136A1
(en)
*
|
2003-08-08 |
2005-02-17 |
Barnes-Jewish Hospital |
Emulsion particles for imaging and therapy and methods of use thereof
|
US7419996B2
(en)
*
|
2003-08-13 |
2008-09-02 |
The University Of Houston |
Parenteral and oral formulations of benzimidazoles
|
CH715855B1
(de)
*
|
2003-08-28 |
2020-08-14 |
Mibelle Ag |
Zubereitung bestehend aus mindestens zwei Nanoemulsionen.
|
EP1510206A1
(en)
|
2003-08-29 |
2005-03-02 |
Novagali Pharma SA |
Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
|
JP2006199589A
(ja)
|
2003-09-03 |
2006-08-03 |
Ltt Bio-Pharma Co Ltd |
生理活性タンパク質またはペプチドを含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる外用剤
|
KR20060110872A
(ko)
|
2003-10-29 |
2006-10-25 |
소너스파머슈티칼즈인코포레이티드 |
토코페롤 변성 치료제 약물 화합물
|
EP1686957B1
(en)
*
|
2003-11-17 |
2012-03-07 |
Sederma |
Compositions containing mixtures of tetrapeptides and tripeptides
|
JP2007526358A
(ja)
*
|
2003-12-17 |
2007-09-13 |
スミスクライン・ビーチャム・コーポレイション |
ポリマーミセル複合体およびそのドラッグデリバリービヒクル
|
NO20035681D0
(no)
|
2003-12-18 |
2003-12-18 |
Amersham Health As |
Optisk avbildning av lungekreft
|
US20050136024A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Stockel Richard F. |
Dermatological compositions
|
EP1547674A1
(en)
|
2003-12-23 |
2005-06-29 |
MediGene Oncology GmbH |
Method for producing colloidal nanoparticles
|
US6974579B2
(en)
|
2004-01-08 |
2005-12-13 |
Allergan, Inc. |
Methods for treating vascular disorders
|
FR2865131B1
(fr)
|
2004-01-15 |
2007-08-24 |
Gattefosse Ets Sa |
Utilisation d'un extrait d'acmella oleracea pour son effet botox like dans une composition cosmetique anti-rides
|
ATE489942T1
(de)
|
2004-01-23 |
2010-12-15 |
Camurus Ab |
Ternäre nichtlamellare lipidzusammensetzungen
|
EP1711163A2
(en)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Dispersions prepared by use of self-stabilizing agents
|
US7118688B2
(en)
|
2004-02-23 |
2006-10-10 |
The Texas A&M University System |
Antioxidant compositions and methods of use thereof
|
DE102004009287A1
(de)
|
2004-02-26 |
2005-09-15 |
Institut Für Neue Materialien Gem. Gmbh |
Amphiphile Nanopartikel
|
CN1946431B
(zh)
|
2004-03-03 |
2011-12-07 |
雷文斯治疗公司 |
用于肉毒毒素的局部施用和透皮递送的组合物和方法
|
US20050214325A1
(en)
|
2004-03-26 |
2005-09-29 |
Vvii Newco 2003, Inc. |
Compositions and methods to increase the effect of a neurotoxin treatment
|
CN1956718A
(zh)
|
2004-03-22 |
2007-05-02 |
细胞基因公司 |
用于治疗和控制皮肤疾病和病症的含免疫调节化合物的组合物和使用方法
|
DE102004016710B4
(de)
|
2004-04-05 |
2020-11-19 |
Greppmayr GmbH |
Formulierung zur Fußpflege
|
EP1586336A1
(en)
|
2004-04-06 |
2005-10-19 |
JOHNSON & JOHNSON GmbH |
Compositions containing copper salts and soy products
|
TW200603843A
(en)
|
2004-04-20 |
2006-02-01 |
Technology Dev Company Ltd |
Tissue enhancement implant and method
|
US20050249686A1
(en)
|
2004-04-27 |
2005-11-10 |
Francoise Pataut |
Cosmetic composition free of water comprising fatty acid esters, petrolatum oil and non-ionic polymers
|
US7591806B2
(en)
|
2004-05-18 |
2009-09-22 |
Bai Xu |
High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
|
US7228259B2
(en)
*
|
2004-06-30 |
2007-06-05 |
Lucent Technologies Inc. |
Method and apparatus for structure-preserving reduced-order modeling
|
GB2416122A
(en)
*
|
2004-07-12 |
2006-01-18 |
Ipsen Ltd |
Botulinum neurotoxin composition
|
CA2799413A1
(en)
*
|
2004-07-26 |
2006-02-23 |
Merz Pharma Gmbh & Co. Kgaa |
Therapeutic composition with a botulinum neurotoxin
|
KR100623013B1
(ko)
|
2004-09-04 |
2006-09-19 |
김영대 |
나노에멀션, 그의 용도 및 제조방법
|
US20060057165A1
(en)
*
|
2004-09-10 |
2006-03-16 |
Dimitrios Dimitrakoudis |
Clostridium botulinum toxin formulation and method for reducing weight
|
US20060073208A1
(en)
|
2004-10-01 |
2006-04-06 |
Allergan, Inc. |
Cosmetic neurotoxin compositions and methods
|
US20060084353A1
(en)
*
|
2004-10-18 |
2006-04-20 |
Wong Tak K |
Reversible ball having hyper-elastic properties
|
KR20070086045A
(ko)
|
2004-11-12 |
2007-08-27 |
이데아 아게 |
피부 상태 치료에서의 확대된 표면 집합체
|
WO2006123354A2
(en)
|
2005-02-02 |
2006-11-23 |
Mega Lifesciences Pvt. Ltd. |
Oral pharmaceutical composition
|
US7727537B2
(en)
*
|
2005-02-14 |
2010-06-01 |
Dpm Therapeutics Corp. |
Stabilized compositions for topical administration and methods of making same
|
CA2494473C
(en)
|
2005-02-14 |
2007-06-26 |
Dpm Therapeutics Corp. |
Stabilized protein compositions for topical administration and methods of making same
|
EP1853303B1
(en)
*
|
2005-02-14 |
2015-12-02 |
DPM Therapeutics Corporation |
Stabilized compositions for topical administration and methods of making same
|
US20080220021A1
(en)
|
2005-02-14 |
2008-09-11 |
Pankaj Modi |
Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis
|
BRPI0608249A2
(pt)
*
|
2005-03-03 |
2009-12-08 |
Revance Therapeutics Inc |
formulação, método para aplicação tópica e kit para distribuição transdérmica de toxina botulìnica
|
JP4444149B2
(ja)
*
|
2005-03-30 |
2010-03-31 |
株式会社ナリス化粧品 |
超微細エマルジョンで構成される皮膚外用剤
|
EP1898947A2
(en)
*
|
2005-06-14 |
2008-03-19 |
Botulinum Toxin Research Associates, Inc. |
Botulinum toxin and the treatment of primary disorders of mood and affect
|
US8926991B2
(en)
*
|
2005-06-14 |
2015-01-06 |
Botulinum Toxin Research Associates, Inc. |
Botulinum toxin and the treatment of primary disorders of mood and affect
|
JP5368793B2
(ja)
|
2005-07-18 |
2013-12-18 |
ユニバーシティ オブ マサチューセッツ ロウエル |
ナノエマルジョンを製造および使用するための組成物および方法
|
CA2618974C
(en)
*
|
2005-08-09 |
2014-01-28 |
Nanobio Corporation |
Nanoemulsion compositions having anti-inflammatory activity
|
US20090306198A1
(en)
|
2005-09-16 |
2009-12-10 |
Robert Nicolosi |
Anti-Oxidant Synergy Formulation Nanoemulsions to Treat Caner
|
US8137677B2
(en)
|
2005-10-06 |
2012-03-20 |
Allergan, Inc. |
Non-protein stabilized clostridial toxin pharmaceutical compositions
|
DE102006046076A1
(de)
|
2005-10-14 |
2007-04-19 |
Henkel Kgaa |
Kosmetische und dermatologische Zusammensetzungen mit Oligopeptiden und Apfelextrakt
|
US10010494B2
(en)
|
2005-10-19 |
2018-07-03 |
Menni Menashe Zinger |
Methods for the treatment of hyperhidrosis
|
CA2628964A1
(en)
*
|
2005-11-09 |
2007-09-07 |
Hormos Medical Ltd. |
Formulations of fispemifene
|
US20070148194A1
(en)
*
|
2005-11-29 |
2007-06-28 |
Amiji Mansoor M |
Novel nanoemulsion formulations
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
TR201901443T4
(tr)
|
2005-12-01 |
2019-02-21 |
Univ Massachusetts Lowell |
Botulinum nanoemülsiyonları.
|
US20070178121A1
(en)
|
2006-01-27 |
2007-08-02 |
Allergan, Inc. |
Methods for enhancing skin treatments
|
US20090053290A1
(en)
|
2006-03-08 |
2009-02-26 |
Sand Bruce J |
Transdermal drug delivery compositions and topical compositions for application on the skin
|
WO2008039245A2
(en)
|
2006-04-27 |
2008-04-03 |
Anterios, Inc. |
Assessment of the effects of topical administration of chemodenervating pharmaceuticals
|
WO2007149868A2
(en)
|
2006-06-20 |
2007-12-27 |
The Regents Of The University Of California |
Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
|
ES2530390T3
(es)
|
2006-07-05 |
2015-03-02 |
Foamix Pharmaceuticals Ltd |
Vehículo espumante de ácido carboxílico y composiciones farmacéuticas del mismo
|
US20100183726A1
(en)
*
|
2006-08-02 |
2010-07-22 |
Robert Nicolosi |
Compositions and methods for treating cancer with dacarbazine nanoemulsions
|
US7445783B2
(en)
*
|
2006-10-30 |
2008-11-04 |
Cappellos, Inc. |
Topical and transdermal treatments using urea formulations
|
US20080206155A1
(en)
|
2006-11-14 |
2008-08-28 |
Foamix Ltd. |
Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
|
BRPI0719732A2
(pt)
|
2006-12-01 |
2017-05-16 |
Anterios Inc |
nanopartículas de peptídeo e usos para as mesmas
|
EP2494958A1
(en)
|
2006-12-01 |
2012-09-05 |
Anterios, Inc. |
Amphiphilic Entity Nanoparticles
|
EP2129364B1
(en)
|
2006-12-21 |
2020-04-15 |
Santen SAS |
Process for manufacturing ophthalmic oil-in-water emulsions
|
EP1938801A1
(en)
|
2006-12-22 |
2008-07-02 |
Biofrontera Bioscience GmbH |
Nanoemulsion
|
ES2660906T3
(es)
|
2007-05-31 |
2018-03-26 |
Anterios, Inc. |
Nanopartículas de ácido nucleico y usos de las mismas
|
US8636982B2
(en)
*
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
MX2010003642A
(es)
|
2007-10-12 |
2010-08-09 |
Massachusetts Inst Technology |
Nanotecnologia de vacuna.
|
WO2009121069A2
(en)
|
2008-03-28 |
2009-10-01 |
University Of Massachusetts |
Compositions and methods for the preparation of nanoemulsions
|
WO2009158687A1
(en)
|
2008-06-26 |
2009-12-30 |
Anterios, Inc. |
Dermal delivery
|
WO2010036652A1
(en)
|
2008-09-23 |
2010-04-01 |
Thomas Jefferson University |
Cancer vaccines against mucosal antigens and methods of making and using the same
|
US20100137357A1
(en)
|
2008-11-26 |
2010-06-03 |
Koleng John J |
Compositions and methods for hyperhidrosis
|
EP2391342A2
(en)
|
2009-01-28 |
2011-12-07 |
Nanobio Corporation |
Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
|
KR20140003572A
(ko)
|
2011-01-24 |
2014-01-09 |
안테리오스, 인코퍼레이티드 |
나노입자 조성물
|
WO2012103040A1
(en)
|
2011-01-24 |
2012-08-02 |
Anterios, Inc. |
Paraben compositions
|
JP2014503587A
(ja)
|
2011-01-24 |
2014-02-13 |
アンテリオス, インコーポレイテッド |
界面活性剤組成物
|
KR20140016275A
(ko)
|
2011-01-24 |
2014-02-07 |
안테리오스, 인코퍼레이티드 |
비어있는 나노입자의 조성물 및 피부 질환을 치료하기 위한 그의 용도
|
US20120328549A1
(en)
|
2011-01-24 |
2012-12-27 |
Anterios, Inc. |
Oil compositions
|
AU2012209274A1
(en)
|
2011-01-24 |
2013-09-12 |
Anterios, Inc. |
Nanoparticle compositions, formulations thereof, and uses therefor
|
WO2015168564A1
(en)
|
2014-05-01 |
2015-11-05 |
Anterios, Inc. |
Methods to treat, prevent, and improve skin conditions
|
AU2015252947B2
(en)
|
2014-05-01 |
2020-07-09 |
Anterios, Inc. |
Demonstrable efficacy across or within patient populations
|